Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
about
N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced effluxRole of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuseHypoinsulinemia regulates amphetamine-induced reverse transport of dopamineRegulation of dopamine transporter activity by carboxypeptidase EPersistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesisImpaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding.Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.Regulation of monoamine transporters: Role of transporter phosphorylation.Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission.A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine ReuptakeRegulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.Insulin signaling and addictionProbing the ability of presynaptic tyrosine kinase receptors to regulate striatal dopamine dynamics.Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons.A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transportersTrafficking of dopamine transporters in psychostimulant actions.
P2860
Q24800348-4736983C-E03C-4A6E-BB35-E0DE1A30C800Q28306056-3986E485-8AAF-4EF5-9E90-10429416A97FQ28469327-5BE2018F-17B0-49C5-BB2F-0BF55F40B077Q28570586-833E1A15-D17C-4037-869D-6C9366016297Q33589580-AF017235-679F-43B4-BE2E-A88D77D38E60Q34039487-268CF906-4848-4850-839B-970779925A0AQ34161514-1DD78C7C-5C8A-4D77-85FD-5D41B3F4E250Q34302349-BCD00F34-B9DE-48CD-A463-8BAC7F5D2275Q34540543-21C219B7-2E94-483E-830A-001FD8C70FE1Q34891738-4A1263B8-22BF-4E5D-8F46-7F9C497D5EB6Q35707905-64BB0D0D-4B98-4330-8BDA-B92F10B6C1B4Q35754644-BCA67107-8D5D-4324-84EF-0DE4B6FB643AQ36341704-9C071DB4-9F9A-45BF-B70F-0D84950373E6Q36457577-2F23B182-471F-4558-8B3F-DA7610054D3DQ36851657-B7314B59-A6DF-41F2-AEA4-57160405844AQ37022861-3CDDE711-1265-42CA-827A-D9FD2DE02FE8Q37312177-15B819E0-6609-4DAD-8393-F679F79D7A2BQ37533305-7213AED1-29FA-4B83-A4B2-A8D4495F4E69
P2860
Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Protein tyrosine kinase inhibi ...... r activity in Xenopus oocytes.
@ast
Protein tyrosine kinase inhibi ...... r activity in Xenopus oocytes.
@en
type
label
Protein tyrosine kinase inhibi ...... r activity in Xenopus oocytes.
@ast
Protein tyrosine kinase inhibi ...... r activity in Xenopus oocytes.
@en
prefLabel
Protein tyrosine kinase inhibi ...... r activity in Xenopus oocytes.
@ast
Protein tyrosine kinase inhibi ...... r activity in Xenopus oocytes.
@en
P1476
Protein tyrosine kinase inhibi ...... r activity in Xenopus oocytes.
@en
P2093
N R Zahniser
P304
P407
P577
2001-03-01T00:00:00Z